Empagliflozin Reactions 1680, p125 - 2 Dec 2017 Glucosuria, severe hypernatraemic dehydration and unconsciousness: case report A 66-year-old man developed glucosuria, severe hypernatraemic dehydration and unconsciousness during treatment with empagliflozin. The man had a history of atrial fibrillation, cardiovascular disease, poorly controlled type 2 diabetes mellitus, arterial hypertension, obesity and hernia of the abdominal wall. He was admitted to the cardiology department for myocardial infarction and later to the neurology department. He was transferred and admitted to the emergency department due to progressive loss of consciousness. He was stuporous on admission. His body temperature was elevated. His BP was low, and he appeared to be dehydrated. Hyperglycaemia, impaired kidney function, severe hyper-tonic hypernatraemia with a sodium level of 165 mmol/L and excessive glucosuria were evident from the laboratory findings. Patchy consolidations in the upper lung fields were evident from the chest X-ray. His medications included rosuvastatin, pantoprazole, valsartan, carvedilol, amlodipine, hydrochlorothiazide and ipratropium bromide. Investigations revealed that empagliflozin 10mg once daily [route not stated] was added to the medications two weeks before the admission for improving glycaemic control. Empagliflozin was considered as a major contributor to hypernatraemia. The man’s therapy with empagliflozin was discontinued. Hypo-tonic fluids were administered. Over the next four days, glucosuria subsided, and the sodium level decreased to 145 mmol/L. The kidney function improved. The fever and free water loss subsided. He regained consciousness. He was transferred back to the neurology department. Author comment: "We considered treatment with empagliflozin as a significant contributor to hypernatraemia in this case. Our hypothesis was supported by a Naranjo score of 6." "[C]ontinuous administration of empagliflozin caused persistent glucosuria and contributed to progressive volume depletion." Gelbenegger G, et al. Severe Hypernatraemic Dehydration and Unconsciousness in a Care-Dependent Inpatient Treated with Empagliflozin. Drug Safety - Case Reports 4: 17, Dec 2017. Available from: URL: https://doi.org/10.1007/ s40800-017-0058-8 - Austria 803285609 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals


Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial